Elaine Castellanos's most recent trade in Reata Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 8,454 Class B common stock done . Disclosure was reported to the exchange on June 7, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | 07 Jun 2021 | 8,454 | 0 | - | - | Class B common stock | ||
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 8,454 | 8,454 | - | - | Class B common stock | |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 8,454 | 9,934 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | 07 Jun 2021 | 8,454 | 23,000 (0%) | 0% | - | Class A common stock | ||
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 141.86 per share. | 07 Jun 2021 | 7,900 | 15,100 (0%) | 0% | 141.9 | 1,120,688 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | 07 Jun 2021 | 1,546 | 16,092 (0%) | 0% | - | Class A common stock | ||
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | 07 Jun 2021 | 1,546 | 0 | - | - | Class B common stock | ||
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 1,546 | 1,546 | - | - | Class B common stock | |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 1,546 | 18,388 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 146.47 per share. | 07 Jun 2021 | 910 | 15,182 (0%) | 0% | 146.5 | 133,287 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 147.16 per share. | 07 Jun 2021 | 636 | 14,546 (0%) | 0% | 147.2 | 93,595 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 142.50 per share. | 07 Jun 2021 | 554 | 14,546 (0%) | 0% | 142.5 | 78,943 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 124.55 per share. | 26 May 2021 | 10,000 | 14,546 (0%) | 0% | 124.5 | 1,245,470 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | 26 May 2021 | 10,000 | 24,546 (0%) | 0% | - | Class A common stock | ||
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | 26 May 2021 | 10,000 | 0 | - | - | Class B common stock | ||
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2021 | 7,066 | 19,934 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2021 | 7,066 | 10,000 | - | - | Class B common stock | |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2021 | 2,934 | 0 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2021 | 2,934 | 2,934 | - | - | Class B common stock | |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 8,000 | 8,000 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Nov 2020 | 600 | 14,546 (0%) | 0% | 0 | Class A common stock | |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 176.02 per share. | 12 Nov 2020 | 3,500 | 15,146 (0%) | 0% | 176.0 | 616,070 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | 12 Nov 2020 | 3,500 | 0 | - | - | Class B common stock | ||
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2020 | 3,500 | 3,500 | - | - | Class B common stock | |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2020 | 3,500 | 2,934 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Elaine Castellanos | VP, Chief Accounting Officer | 12 Nov 2020 | 3,500 | 18,646 (0%) | 0% | - | Class A common stock |